These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8420595)

  • 1. meta-Chlorophenylpiperazine decreases slow-wave sleep in humans.
    Katsuda Y; Walsh AE; Ware CJ; Cowen PJ; Sharpley AL
    Biol Psychiatry; 1993 Jan; 33(1):49-51. PubMed ID: 8420595
    [No Abstract]   [Full Text] [Related]  

  • 2. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
    Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
    Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Implications of 5-HT2 receptors in the increase of slow wave sleep in healthy volunteers under amoxapine].
    Loas G
    Encephale; 1991 Dec; 17 Spec No 3():423-5. PubMed ID: 1807968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?
    Friston KJ; Sharpley AL; Solomon RA; Cowen PJ
    Psychopharmacology (Berl); 1989; 98(1):139-40. PubMed ID: 2498958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients.
    Benkelfat C; Murphy DL; Hill JL; George DT; Nutt D; Linnoila M
    Arch Gen Psychiatry; 1991 Apr; 48(4):383. PubMed ID: 2009039
    [No Abstract]   [Full Text] [Related]  

  • 6. Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine.
    Sharpley AL; Vassallo CM; Pooley EC; Harrison PJ; Cowen PJ
    Psychopharmacology (Berl); 2001 Jan; 153(2):271-2. PubMed ID: 11205431
    [No Abstract]   [Full Text] [Related]  

  • 7. A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers.
    Lawlor BA; Newhouse PA; Balkin TJ; Molchan SE; Mellow AM; Murphy DL; Sunderland T
    Biol Psychiatry; 1991 Feb; 29(3):281-6. PubMed ID: 2015332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
    Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
    Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1-like receptor agonists enhance wakefulness.
    Dzoljic MR; Ukponmwan OE; Saxena PR
    Neuropharmacology; 1992 Jul; 31(7):623-33. PubMed ID: 1407402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra.
    Landolt HP; Meier V; Burgess HJ; Finelli LA; Cattelin F; Achermann P; Borbély AA
    Neuropsychopharmacology; 1999 Sep; 21(3):455-66. PubMed ID: 10457543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety.
    Gatch MB
    Life Sci; 2003 Aug; 73(11):1347-67. PubMed ID: 12850497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls.
    Seifritz E; Gillin JC; Rapaport MH; Kelsoe JR; Bhatti T; Stahl SM
    Biol Psychiatry; 1998 Jul; 44(1):21-33. PubMed ID: 9646880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
    van Laar M; Volkerts E; Verbaten M
    Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2C receptor activation decreases appetite and body weight in obese subjects.
    Sargent PA; Sharpley AL; Williams C; Goodall EM; Cowen PJ
    Psychopharmacology (Berl); 1997 Oct; 133(3):309-12. PubMed ID: 9361339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L; Ursin R
    Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Headache induced by serotonergic agonists--a key to the interpretation of migraine pathogenesis?
    Panconesi A; Sicuteri R
    Cephalalgia; 1997 Feb; 17(1):3-14. PubMed ID: 9051329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats.
    Freo U; Soncrant TT; Ricchieri GL; Wozniak KM; Larson DM; Rapoport SI
    Brain Res; 1990 Mar; 511(2):209-16. PubMed ID: 2334843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates.
    Szele FG; Murphy DL; Garrick NA
    Life Sci; 1988; 43(16):1297-303. PubMed ID: 3172981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
    Cohen ML; Fuller RW
    Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.